338
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy

, MD, , MD, , MD, , MD & , MD
Pages 48-54 | Received 10 Jun 2017, Accepted 30 Aug 2017, Published online: 25 Sep 2017

REFERENCES

  • Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703–7720.
  • Veronesi U, Viale G, Paganelli G, et al. Sentinel lymph node biopsy in breast cancer: Ten-year results of a randomized controlled study. Ann Surg. 2010;251:595–600.
  • Ivens D, Hoe AL, Podd TJ, et al. Assessment of morbidity from complete axillary dissection. Br J Cancer. 1992;66:136–138.
  • Ozaslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg. 2004;187:69–72.
  • Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. JAMA. 2011;305:569–575.
  • Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252:426–432; discussion 432–3.
  • Dengel LT, Van Zee KJ, King TA, et al. Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy. Ann Surg Oncol. 2014;21:22–27.
  • Yi M, Kuerer HM, Mittendorf EA, et al. Impact of the American college of surgeons oncology group Z0011 criteria applied to a contemporary patient population. J Am Coll Surg. 2013;216:105–113.
  • Roberts A, Nofech-Mozes S, Youngson B, et al. The importance of applying ACOSOG Z0011 criteria in the axillary management of invasive lobular carcinoma: A multi-institutional cohort study. Ann Surg Oncol. 2015;22:3397–3401.
  • Lyman GH, Somerfield MR, Bosserman LD, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol. 2016;35:561–564.
  • Latosinsky S, Berrang TS, Cutter CS, et al. CAGS and ACS evidence based reviews in surgery. 40. Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis. Can J Surg. 2012;55:66–69.
  • Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981–22023 AMAROS): A randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15:1303–1310.
  • Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): A phase 3 randomised controlled trial. Lancet Oncol. 2013;14:297–305. Erratum in: Lancet Oncol. 2013;14:e254.
  • Madsen EV, van Dalen J, van Gorp J, et al. Frozen section analysis of sentinel lymph nodes in patients with breast cancer does not impair the probability to detect lymph node metastases. Virchows Arch. 2012;460:69–76.
  • Fu MR. Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management. World J Clin Oncol. 2014;5:241–247.
  • Sávolt Á, Péley G, Polgár C, et al. Eight-year follow up result of the OTOASOR trial: The optimal treatment of the axilla–surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial. Eur J Surg Oncol. 2017;43:672–679.
  • Offersen BV, Nielsen HM, Overgaard M, et al. Is regional nodes radiotherapy an alternative to surgery? Breast. 2013;22(Suppl 2):S118–S128.
  • Kuru B, Sullu Y, Yuruker S, et al. Factors predicting non-sentinel lymph node metastasis in T1-2 invasive breast cancer with 1–2 axillary sentinel lymph node metastases: Presentation of Ondokuz Mayis scoring system. J BUON. 2016;21:1129–1136. Erratum in: J BUON 2016;21:1571.
  • Meretoja TJ, Leidenius MH, Heikkilä PS, et al. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer. J Natl Cancer Inst. 2012;104:1888–1896.
  • Chung MA, DiPetrillo T, Hernandez S, et al. Treatment of the axilla by tangential breast radiotherapy in women with invasive breast cancer. Am J Surg. 2002;184:401–402.
  • Rabinovitch R, Ballonoff A, Newman F, et al. Evaluation of breast sentinel lymph node coverage by standard radiation therapy fields. Int J Radiat Oncol Biol Phys. 2008;70:1468–1471.
  • Veronesi U, Orecchia R, Zurrida S, et al. Avoiding axillary dissection in breast cancer surgery: A randomized trial to assess the role of axillary radiotherapy. Ann Oncol. 2005;3:383–388.
  • Whelan TJ, Olivotto IA, Parulekar WR, et al. Regional nodal irradiation in early-stage breast cancer. N Engl J Med. 2015;373:307–316.
  • Poortmans PM, Collette S, Kirkove C, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373:317–327.
  • Shaitelman SF, Chiang YJ, Griffin KD, et al. Radiation therapy targets and the risk of breast cancer-related lymphedema: A systematic review and network meta-analysis. Breast Cancer Res Treat. 2017;162:201–215. Erratum in: Breast Cancer Res Treat. 2017;162:217.
  • Sanuki N, Takeda A, Amemiya A, et al. Outcomes of clinically node-negative breast cancer without axillary dissection: Can preserved axilla be safely treated with radiation after a positive sentinel node biopsy? Clin Breast Cancer. 2013;13:69–76.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.